Figure 2. A patient with HNSCC showed partial response (−54%) on the first restaging scan.
The baseline and the first restaging CT scan of a 60-year-old woman with squamous cell carcinoma of the base of the tongue who had received prior cetuximab.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.